Navigation Links
CV Therapeutics Reports 2008 Third Quarter Financial Results
Date:11/6/2008

- Ranexa(R) net revenue grows 19 percent quarter-over-quarter -

PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today reported financial results for the third quarter ended September 30, 2008.

For the quarter ended September 30, 2008, the Company reported a net loss of $25.4 million, or $0.41 per share. This compares to a net loss of $34.2 million, or $0.58 per share, for the same quarter in 2007 and $4.3 million, or $0.07 per share, for the prior quarter ended June 30, 2008. Excluding the impact of the $22.0 million milestone revenue recognized in the quarter ended June 30, 2008, the prior quarter net loss would have been $26.3 million. The milestone payments received in the second quarter of 2008 were $12.0 million from Astellas Pharma U.S. Inc. (Astellas) associated with the U.S. Food and Drug Administration approval for Lexiscan(R) (regadenoson) injection and $10.0 million relating to a milestone payment from TPG-Axon Capital associated with the commercial launch of Lexiscan(R).

For the quarter ended September 30, 2008, the Company recorded $30.3 million of net product sales of Ranexa(R) (ranolazine extended-release tablets) in the U.S., which represents an increase of 19 percent compared to the $25.4 million of net product sales recorded in the prior quarter ended June 30, 2008 and an increase of 65 percent compared to the $18.4 million of net product sales recorded in the same quarter in the prior year.

For the quarter ended September 30, 2008, the Company recorded total revenues of $38.1 million, which consisted of $30.3 million of net product sales of Ranexa, $4.7 million of royalty and license revenue and $3.2 million of collaboration, milestone and other reve
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
2. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
3. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
4. Nile Therapeutics to Present at Two Upcoming Investor Conferences
5. Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
6. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
8. United Therapeutics Reports Third Quarter 2008 Financial Results
9. Arete Therapeutics Bolsters Management Team
10. Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics
11. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013 The Stirling ... Global Cooling, Inc., Athens, OH, USA, won the Outstanding ... the International Society for Biological and Environmental Repositories (ISBER) ... given to one product annually, recognizes the company’s development ... temperature freezer. The award was presented to Global ...
(Date:5/16/2013)... 2013 A new selection of ... Cole-Parmer is designed to meet the dynamic needs ... The new Cole-Parmer® MS-3400 Centrifuges are ... lab. They ensure a powerful and complete separation ... Their standard four-place swinging buckets hold 50-mL tubes. ...
(Date:5/16/2013)...  The registration deadline has been extended until May ... National Conference, the premier conference for bioscience financial officers. ... Hilton San Diego Bayfront. "We are ... want to make sure as many people as possible ... Roberts , Chief Financial Officer of Mast Therapeutics, ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... Analysis: Therapeutic Proteins – Biosimilars, Biobetters ...   Product ... The new Competitive Intelligence Report Therapeutic ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... Foundation (NSF) has awarded Northwestern University a six-year, $16.2 ... and Engineering Center (MRSEC), one of the oldest interdisciplinary ... which integrates educational activities with a scientific research program, ... Centers in the nation to successfully renew support from ...
... 8, 2011 HUYA Bioscience International, ... announced a strategic partnership with the Zhejiang Chinese ... will accelerate the global drug development of China,s ... partnership is expected to bring productive synergy between ...
... YORK, Sept. 8, 2011 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p0611062/Global-High-Throughput-Screening-HTS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc This ... Throughput Screening (HTS) in US$ Million. The ...
Cached Biology Technology:Collaborative science and engineering 2HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College 2HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College 3Global High Throughput Screening (HTS) Industry 2Global High Throughput Screening (HTS) Industry 3Global High Throughput Screening (HTS) Industry 4Global High Throughput Screening (HTS) Industry 5Global High Throughput Screening (HTS) Industry 6Global High Throughput Screening (HTS) Industry 7Global High Throughput Screening (HTS) Industry 8
(Date:5/17/2013)... Tibetan antelope can live at elevations of 4,000-5,000m ... published in Nature Communications , investigators from ... that some genetic factors may be associated with ... data in this work will also provide implications ... of other ruminant species. , The Tibetan antelope ...
(Date:5/17/2013)... of American Societies for Experimental Biology (FASEB) released a ... (NIH) funding trends highlighting the devastating impact of sequestration ... FASEB analysis follows a May 15th Senate Appropriations Committee ... testified that the $1.6 billion cut the agency sustained ... substantial impact on the scientific community." , According ...
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... Annual Meeting in San Francisco, CA from June ... the entry of students, postdoctorates and scientists from ... science community and to encourage the participation of ... , Awards are given to poster/platform presenters and ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... California, Davis, and the University of Colorado at Boulder puts ... cells, divide. The work, which could have implications for a ... 2) in the journal Science . "It,s a ... chair of molecular cell biology at UC Davis and a ...
... funding is hard to come by, a University of Central ... million in National Institutes of Health highly competitive grants for ... five years is aimed at determining whether a green technique ... more effective. The second grant worth $2 million for four ...
... from Louisiana Tech University will be floating high above ... testing of an experimental DNA analysis instrument developed at ... Niel Crews, assistant professor of mechanical engineering, and Collin ... Micromanufacturing (IfM) say the instrument could be used to ...
Cached Biology News:New insight in how cells' powerhouse divides 2Hemophilia research gets NIH boost to a tune of $5.5 million 2Hemophilia research gets NIH boost to a tune of $5.5 million 3Louisiana Tech University researchers, NASA partner to conduct zero-gravity experiments 2
Request Info...
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
...
Recombinant Feline IL-5...
Biology Products: